Although no definite conclusion could be reached on the safety of VGB in kids less than 2 years old due to the limited amount of information, we want to emphasize that VGB in infants and young children seems to be safer about VAVFL. Only 3% of children under 2 years of age manifested VAVFL on a large cohort of 222 patients, showing that a younger age (under 2 years of age) could represent a protective factor against VAVFL complications.
Vigabatrin in paediatric epilepsy: further lesson / Parisi, Pasquale; R., Bombardieri; P., Curatolo. - In: EPILEPSIA. - ISSN 0013-9580. - STAMPA. - 49:1(2008), pp. 177-178. [10.1111/j.1528-1167.2007.01329_2.x]
Vigabatrin in paediatric epilepsy: further lesson
PARISI, Pasquale
;
2008
Abstract
Although no definite conclusion could be reached on the safety of VGB in kids less than 2 years old due to the limited amount of information, we want to emphasize that VGB in infants and young children seems to be safer about VAVFL. Only 3% of children under 2 years of age manifested VAVFL on a large cohort of 222 patients, showing that a younger age (under 2 years of age) could represent a protective factor against VAVFL complications.| File | Dimensione | Formato | |
|---|---|---|---|
|
Parisi_Vigabatrin_2008.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.33 MB
Formato
Adobe PDF
|
3.33 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
